|

Zimberelimab (ZIM) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: AB122, GS-0122

Pipeline

Phase 2: 1

Top Sponsors

  • Gilead Sciences1

Indications

  • Resectable Non-Small-Cell Lung Cancer1
  • Advanced or Metastatic Non-small Cell Lung Cancer1
  • Lung Cancer1
  • Cancer1

Tucson, Arizona1 trial

Study of Novel Treatment Combinations in Patients With Lung Cancer

Arizona Oncology Associates,Substudy-01

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.